scholarly journals Editorial: Pathomechanisms and Treatments to Protect the Preterm, Fetal Growth Restricted and Neonatal Encephalopathic Brain

2021 ◽  
Vol 12 ◽  
Author(s):  
Bobbi Fleiss ◽  
Deidre M. Murray ◽  
S. Tracey Bjorkman ◽  
Julie A. Wixey
Keyword(s):  
1996 ◽  
Vol 22 (1) ◽  
pp. 37-53 ◽  
Author(s):  
E Petridou ◽  
D Trichopoulos ◽  
K Revinthi ◽  
D Tong ◽  
E Papathoma
Keyword(s):  

2000 ◽  
Vol 42 (01) ◽  
pp. 14 ◽  
Author(s):  
Stephen R Zubrick ◽  
Jennifer J Kurinczuk ◽  
Brett M C McDermott ◽  
Robert S McKelvey ◽  
Sven R Silburn ◽  
...  

2008 ◽  
Vol 68 (S 01) ◽  
Author(s):  
B Meurer ◽  
B Meurer ◽  
N Dinkel ◽  
N Hart ◽  
J Siemer ◽  
...  

1989 ◽  
Vol 61 (02) ◽  
pp. 243-245 ◽  
Author(s):  
J G Thornton ◽  
B J Molloy ◽  
P S Vinall ◽  
P R Philips ◽  
R Hughes ◽  
...  

SummaryA panel of haemostatic tests was perfomed on 400 primiparous women at 28 weeks to test whether one or more could predict the development of pregnancy complications. Fifteen women subsequently developed pre-eclampsia with significant proteinuria and 13 delivered growth retarded infants. There were no significant differences between mothers in the pre-eclampsia group and 22 randomly selected controls. A stepwise logistic discriminant analysis of the data did not produce a significant model. In the growth retarded group only beta thromboglobulin levels were significantly lower than in the controls (p <0.05), although in the logistic discriminant analysis the inclusion of both beta thromboglobulin and fibrin degradation products led to a borderline significant improvement in fit of the model. We conclude that the haemostatic variables studied are not significantly changed at 28 weeks nor clinically useful predictors of either pre-eclampsia or fetal growth retardation.


Sign in / Sign up

Export Citation Format

Share Document